Arcutis Biotherapeutics

ARQT

28.2602.65% ( +0.730 )

已收盘: 11月13日 16:00:00 (美东)

主要股东最新
股东
BlackRock, Inc.	14.04%	1,775.14 万	5.64%	+720.60 万	2026/09/30
Montanova Capital, LLC	9.84%	1,243.70 万	0.02%	+11.00 万	2026/06/30
Frazier Life Sciences Management, LP	7.81%	987.45 万	0.09%	+0	2026/06/30
Rubric Capital Management LP	6.54%	827.16 万	0.07%	+0	2026/06/30
State Street Investment Management	6.10%	771.86 万	1.47%	+189.58 万	2026/09/30
Polar Capital Holdings Plc	5.22%	660.69 万	0.69%	+94.00 万	2026/06/30
Vanguard Capital Management, LLC	4.59%	580.39 万	0.08%	+16.06 万	2026/06/30
UBS Asset Management AG	4.56%	576.42 万	1.72%	+220.00 万	2026/09/30
Morgan Stanley	3.47%	438.91 万	0.15%	+23.27 万	2026/06/30
Jennison Associates LLC	3.34%	421.91 万	0.02%	+0	2026/09/30
D. E. Shaw & Co., L.P.	3.12%	394.96 万	1.13%	+145.34 万	2026/06/30
Geode Capital Management, LLC	2.35%	297.07 万	0.03%	-1.17 万	2026/09/30
Bank of America Corporation	2.17%	274.80 万	0.62%	+80.24 万	2026/06/30
Medical Strategy GmbH	2.10%	265.19 万	0.02%	+0	2025/12/31
Vanguard Portfolio Management, LLC	1.92%	242.90 万	0.36%	+47.43 万	2026/06/30
OrbiMed Advisors LLC	1.61%	204.20 万	--	+204.20 万	2026/06/30
Franklin Templeton Inc.	1.56%	197.66 万	0.03%	+4.58 万	2026/09/30
American Century Investment Management Inc	1.56%	197.59 万	0.03%	+5.09 万	2026/09/30
Janus Henderson Group Ltd.	1.12%	141.04 万	0.37%	-44.41 万	2026/06/30
Oberweis Asset Management, Inc.	1.09%	137.29 万	<0.01%	+7,000.00	2026/06/30

股东